Related Experiment Videos

HTLV-1-associated myelopathy/tropical spastic paraparesis with pseudohypoparathyroidism

N Machigashira1, Y Yoshida, S Wang

  • 1Third Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Sakuragaoka, Kagoshima, Japan.

Neurology
|January 10, 2001
PubMed

Insights

Pseudohypoparathyroidism (PHP) may increase the risk of developing human T-lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In short-stature patients, PHP signs were identified, suggesting a link between these conditions.

Area of Science:

  • Neurology
  • Endocrinology
  • Immunology

Background:

  • Human T-lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) can manifest in childhood.
  • Short stature is a common feature in some patients with HAM/TSP.

Purpose of the Study:

  • To investigate the potential link between short stature, pseudohypoparathyroidism (PHP), and HAM/TSP.
  • To determine if PHP is a risk factor for developing HAM/TSP.

Main Methods:

  • Investigated 14 short-stature patients for signs of PHP.
  • Utilized diagnostic methods including metacarpal analysis, parathyroid hormone infusion tests, and molecular assays (Gsalpha immunoblotting and Northern blotting).

Main Results:

  • 12 out of 14 short-stature patients exhibited findings consistent with pseudohypoparathyroidism (PHP).
  • Patients with PHP showed a modified immunologic status, suggesting a predisposition to HAM/TSP.
  • Human T-lymphotrophic virus type I infection was not found to cause PHP.

Conclusions:

  • Pseudohypoparathyroidism (PHP) may be a significant risk factor for the development of HAM/TSP.
  • The findings suggest an interplay between genetic/endocrine conditions like PHP and infectious neurological diseases like HAM/TSP.

Related Concept Videos